期刊文献+

乳癌改良根治术三种插管全麻方法的麻醉效果比较 被引量:1

THE CLINICAL EFFECT OF THREE DIFFERENT METHODS OF INTUBATION ANESTHESIA FOR MODIFIED MASTECTOMY
下载PDF
导出
摘要 目的研究乳腺癌改良根治术三种插管全麻方法,评选最佳方案。方法选择90例乳腺癌患者,采用随机方法分组,分为全凭吸入全麻(VCA)、硬膜外吸入复合全麻(VECA)、静脉吸入复合全麻(VI-CA),比较三组血流动力学、术后苏醒情况及拔管时间。结果 各组麻醉诱导后、切皮时平均动脉压(MAP)、心率(HR)无明显变化(p<0.05),手术结束后,VCA组MAP稍升高、HR稍增快。VECA和VICA组,血流动力学无明显变化,术后苏醒较快,拔管时间较早。静脉吸入复合全麻(VICA)组苏醒质量最佳。结论乳癌改良根治术可选择(VECA)、(VICA)麻醉。VICA更安全有效,苏醒快。 Objective This study was designed to compare three kinds of intubation anesthesia methods in modified mastectomy to select the appropriate method of anesthesia.Methods 90 patients undergoing radical mastectomy were divided into VCA,VECA and VICA groups randomly.Each has 30 cases.Observed on average artery pressure(MAP),heart rate(HR),analgesia quality,recovery of anesthesia and time of extubation.Results MAP and HR remained stable and no complications of anesthesia after tracheal intubation and skin incison in all patients.When the operation were over,in VCA group,MAP higher and HR increased obviously than others.VECA and VICA group showed significant less hemodynamic changes and better consciousness recovery than VCA group.The Consciousness recovery in Group VICA is the best.Conclusion VECA and VICA should be selected anesthesia for undergoing radical mastectomy,while VICA is safe and effective,recovery faster from operation.
出处 《现代医院》 2010年第12期27-28,共2页 Modern Hospitals
关键词 乳腺癌改良根治术 气管插管 血流动力学 醒恢复 VCA VECA VICA Modified mastectomy Intubation Hemodynamics Consciousness recovery VCA VECA VICA
  • 相关文献

参考文献6

二级参考文献36

  • 1郭巨灵.临床骨科学[M].北京:人民卫生出版社,1991.430.
  • 2[1]James MK,Vuong A,Grizzle MK,et al.Hemodynamic effects of GI87084B,an ultra-short acting mu-opioid analgesic,in anesthetized dogs[J].J Pharmacol Exp Ther,1992,263(1):84-91.
  • 3[2]Amin HM,Sopchak AM,Esposito BF,et al.Naloxone-induced and spontaneous reversal of depressed ventilatory responses to hypoxia during and after continuous infusion of remifentanil or alfentanil[J].J Pharmacol Exp Ther,1995,274(1):34-39.
  • 4[3]Reves JG.Educational considerations for the clinical introduction and use of remifentanil[J].Anesth Analg,1999,89(Suppl 4):4-6.
  • 5[4]Glass PS,Hardman D,Kamiyama Y,et al.Preliminary pharmacokinetics and pharmacodynamics of an ultra-short-acting opioid:remifentanil(GI87084B)[J].Anesth Analg,1993,77(5):1031-1040.
  • 6[5]Dershwitz M,Hoke JF,Rosow CE,et al.Pharmacokinetics and pharmacodynamics of remifentanil in volunteer subjects with severe liver disease[J].Anesthesiology,1996,84(4):812-820.
  • 7[6]Hoke JF,Shlugman D,Dershwitz M,et al.Pharmacokinetics and pharmacodynamics of remifentanil in persons with renal failure compared with healthy volunteers[J].Anesthesiology,1997,87(3):533-541.
  • 8[7]Jhaveri R,Joshi P,Batenhorst R,et al.Dose comparison of remifentanil and alfentanil for loss of consciousness[J].Anesthesiology,1997,87(2):253-259.
  • 9[8]Lang E,Kapila A,Shlugman D,et al.Reduction of isoflurane minimal alveolar concentration by remifentanil[J].Anesthesiology,1996,85(4):721-728.
  • 10[9]Westmoreland CL,Hoke JF,Sebel PS,et al.Pharmacokinetisc of remifentanil(GI87084B) and its major metabolite(GI9029) in patients undergoing elective inpatient surgery[J].Anesthesiology,1993,79(5):893-903.

共引文献197

同被引文献5

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部